BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2013
View Archived Issues
Elan profiles PLK-2 inhibitor ELN-582646 for the treatment of Parkinson's disease
Read More
Scientists discover novel small-molecule inhibitor of drug-resistant tuberculosis
Read More
Uncovering an amygdala-based mechanism and a potential drug target of PTSD
Read More
Auspex commences First-HD phase III trial of SD-809 in Huntington's disease
Read More
Omni Bio to provide funding for clinical trial of alpha-1-antitrypsin in GVHD
Read More
Hisamitsu Pharmaceutical begins phase II study of HP-3060
Read More
Vernalis begins phase Ib/II study of V-81444
Read More
Daiichi Sankyo reports results from phase III study of antiplatelet agent in Japan
Read More
Nymox reports data from pivotal trial of NX-1207
Read More
Namisol shows efficacy in treatment of spasticity and pain in MS
Read More
RXi Pharmaceuticals reports findings from second phase I study of RXI-109
Read More
Lilly reports promising result for LY-2409021 in patients with type 1 and 2 diabetes
Read More
Allergan patents novel prostanoid receptor antagonists
Read More
Millennium Pharmaceuticals divulges PI3K type 3 inhibitors
Read More
Tissue transglutaminase inhibitors emerge from Sanofi R&D
Read More
Alios BioPharma patent describes agents for RSV and influenza
Read More
CSIR researchers develop agents for tuberculosis
Read More
COPD withdrawn from Japanese NDA for fluticasone furoate/vilanterol
Read More
Diazepam nasal spray shows safety and bioavailability comparable to marketed rectal gel formulation
Read More
Ipsen and Harvard to collaborate on novel engineered botulinum toxins
Read More
FDA approves Gilotrif along with companion diagnostic for first-line treatment of metastatic NSCLC
Read More
FDA and EMA issue decisions regarding C-Path's trial simulation tool for Alzheimer's disease
Read More
Promising first data for AbbVie compound in mild to moderate Alzheimer's disease
Read More
PI3Kbeta inhibitors revealed in GlaxoSmithKline patent
Read More